Searched for
FDA CHIEF
No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling caseThe Maharashtra government has assured the Bombay High Court it will halt raids and confiscations concerning ayurvedic product labels. This...- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- Pune hooch tragedy: Toll rises to 17 as 22 police, excise officials suspended, methanol supplier tracedA spurious liquor tragedy in Pune and Pimpri Chinchwad has claimed 17 to 18 lives. Most victims were daily wage labourers. The state govern...
- FDA drug center head fired after commissioner's exit, replaced by DavisThe U.S. Food and Drug Administration's drug center sees a leadership change as acting head Tracy Beth Hoeg departs, replaced by deputy Mic...
- Hims earnings today: Why Hims & Hers Health stock dropped despite raising revenue forecast - here's what investors need to knowHims stock after Hims & Hers earnings: Hims & Hers Health shares dropped significantly after reporting a surprise first-quarter loss and re...
- Guardant Health to launch blood-based cancer test in India with Zydus LifesciencesGuardant Health is set to introduce a groundbreaking blood test in India for early cancer detection. This multi-cancer test, co-marketed by...
- FDA official overseeing vaccines resigns amidst controversyA key US Food and Drug Administration official responsible for vaccines is departing at the end of April. Vinay Prasad faced criticism for ...
- Controversial FDA official Dr Vinay Prasad regains Chief Medical Officer titleDr. Vinayak Prasad has been re-appointed as the FDA's Chief Medical and Scientific Officer and Director of CBER. He will advise senior offi...
- Dr Vinay Prasad's FDA exit in less than 3 months linked to Sarepta gene therapy controversy? Check detailsDr. Vinay Prasad, a controversial figure and critic of the FDA, resigned from his high-ranking position at the agency after less than three...
- Vinay Prasad, US FDA's chief medical and science officer, departs agencyVinay Prasad, the Food and Drug Administration's chief medical and science officer, resigned. He cited a desire to return to California and...
- Covid omicron vaccinations approved by FDA for use in infants as young as 6 monthsThe FDA is urging people to be up to date with all vaccines. Now children as young as 6 months old can get the new Omicron booster dose.
- FDA chief to detail delays inspecting baby formula plantFederal plans to inspect a baby formula factory linked to the nationwide shortage were slowed by COVID-19, scheduling conflicts and other l...
- FDA chief apologises for overstating plasma effect on virusThe announcement on the eve of Trump's Republican National Convention raised suspicions that it was politically motivated to offset critics...
- US FDA chief’s exit could impact Indian pharmaSeveral Indian drug firms had to recall medicines after a clamp down by the US regulator.
- USFDA chief supports generics made in IndiaThe Indian drug makers are finally seeing a recovery with most of their factories being cleared by the US watchdog.
- Maharashtra FDA chief pitches for Make in India in food processingThe three-day trade show will have a series of panel discussions on global food trends, how they will play out in South-East Asia.
- UP food regulator finds lead in Yippee noodles; to file caseThe FDA said that the samples of Yippee noodles, seized from a local mall here, have been found to contain lead "far in excess to the permi...
- Sufficient stock of swine flu drugs in Maharashtra: FDA chiefHospitals in Maharashtra, both government and semi-government, have sufficient stock of swine flu drugs which are available for free, said ...
- India should be proud of pharma companies like Dr. Reddy and Lupin: Jagdish Malkani, NSE & BSEJagdish Malkani, Member NSE & BSE, shares his views on pharma space.
Load More
